4.7 Review

Targeting Aggressive Pituitary Adenomas at the Molecular Level-A Review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas

Odelia Cooper et al.

Summary: This study evaluated the effect of lapatinib, a tyrosine kinase inhibitor, on aggressive prolactinomas that are resistant to dopamine agonist therapy. While none of the participants achieved the primary endpoint, three showed stable disease and lapatinib was generally well tolerated with reversible side effects.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Oncology

Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor

Valentine Suteau et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Review Clinical Neurology

Dopamine agonist and tamoxifen combination therapy for a prolactin-secreting pituitary tumor resistant to dopamine agonist monotherapy: Case report and review

Zachary K. Christian et al.

INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT (2020)

Article Endocrinology & Metabolism

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours

Donato Iacovazzo et al.

ENDOCRINE (2020)

Review Endocrinology & Metabolism

Advances in the medical treatment of Cushing's syndrome

Richard A. Feelders et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

Article Endocrinology & Metabolism

THE EFFECT OF RALOXIFENE ON SERUM PROLACTIN LEVEL IN PATIENTS WITH PROLACTINOMA

Chitra Choudhary et al.

ENDOCRINE PRACTICE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden

Thomas A. Hope et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Clinical Neurology

Augmented Reality in Transsphenoidal Surgery

Barbara Carl et al.

WORLD NEUROSURGERY (2019)

Article Endocrinology & Metabolism

Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience

G. Giuffrida et al.

ENDOCRINE CONNECTIONS (2019)

Review Immunology

Immune checkpoint inhibitors: The linchpins of modern immunotherapy

Breelyn A. Wilky

IMMUNOLOGICAL REVIEWS (2019)

Article Clinical Neurology

Medical Management of Cushing Disease

Nicholas A. Tritos et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2019)

Article Oncology

Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma A Single-Center, Open-Label, 2-Year Randomized Clinical Trial

Rafael L. Batista et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2019)

Article Oncology

Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness

Pedro Marques et al.

ENDOCRINE-RELATED CANCER (2019)

Article Endocrinology & Metabolism

Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas

Dongyun Zhang et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Biochemistry & Molecular Biology

Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study

Ricarda Hannen et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)

Article Endocrinology & Metabolism

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Gerald Raverot et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

Review Biochemistry & Molecular Biology

Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer

Shang-Gin Wu et al.

MOLECULAR CANCER (2018)

Review Biochemistry & Molecular Biology

EGFR-TKIs resistance via EGFR-independent signaling pathways

Qian Liu et al.

MOLECULAR CANCER (2018)

Review Pharmacology & Pharmacy

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment

Hitisha K. Patel et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Andre Lacroix et al.

LANCET DIABETES & ENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab

Andrew L. Lin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Review Biochemistry & Molecular Biology

Immune checkpoint inhibitors: recent progress and potential biomarkers

Pramod Darvin et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Article Medicine, General & Internal

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. D. Wolchok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

J. Strosberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Endocrinology & Metabolism

Overview of the 2017 WHO Classification of Pituitary Tumors

Ozgur Mete et al.

ENDOCRINE PATHOLOGY (2017)

Article Endocrinology & Metabolism

Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients

Pia Burman et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists

Y. Greenman et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Cabergoline treatment for recurrent Cushing's disease during pregnancy

Afif Nakhleh et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2016)

Article Biochemistry & Molecular Biology

Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro

Shi-qi Cheng et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2016)

Article Medicine, General & Internal

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Martin Reck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Toxicology

Microsatellite instability: an update

Hiroyuki Yamamoto et al.

ARCHIVES OF TOXICOLOGY (2015)

Article Cell Biology

Recurrent gain-of-function USP8 mutations in Cushing's disease

Zeng-Yi Ma et al.

CELL RESEARCH (2015)

Article Multidisciplinary Sciences

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Naiyer A. Rizvi et al.

SCIENCE (2015)

Article Neurosciences

Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications

Christian P. Miermeister et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)

Article Genetics & Heredity

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

Martin Reincke et al.

NATURE GENETICS (2015)

Article Endocrinology & Metabolism

Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma

Frederique Albarel et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Review Oncology

The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas

Eric Monsalves et al.

ENDOCRINE-RELATED CANCER (2014)

Article Endocrinology & Metabolism

Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease

Susan M. Webb et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)

Article Medicine, General & Internal

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Multidisciplinary Sciences

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett E. Johnson et al.

SCIENCE (2014)

Article Endocrinology & Metabolism

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

Odelia Cooper et al.

ENDOCRINE (2014)

Article Environmental Sciences

Bisphenol S Disrupts Estradiol-Induced Nongenomic Signaling in a Rat Pituitary Cell Line: Effects on Cell Functions

Rene Vinas et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2013)

Article Cell Biology

Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene

David J. Wright et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2013)

Article Biotechnology & Applied Microbiology

Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat

Benjamin Voellger et al.

ONCOTARGETS AND THERAPY (2013)

Article Immunology

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth

Petra Hamerlik et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Article Endocrinology & Metabolism

Anti-VEGF therapy in pituitary carcinoma

Leon D. Ortiz et al.

PITUITARY (2012)

Review Biochemistry & Molecular Biology

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Chrisostomi Gialeli et al.

FEBS JOURNAL (2011)

Article Medicine, Research & Experimental

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

Hidenori Fukuoka et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Oncology

Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors

Eduardo Vilar et al.

MOLECULAR CANCER THERAPEUTICS (2011)

Article Endocrinology & Metabolism

HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy

Hidenori Fukuoka et al.

MOLECULAR ENDOCRINOLOGY (2011)

Review Biotechnology & Applied Microbiology

Rapamycin passes the torch: a new generation of mTOR inhibitors

Don Benjamin et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Review Biochemistry & Molecular Biology

Matrix metalloproteinases: Fold and function of their catalytic domains

Cynthia Tallant et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)

Article Endocrinology & Metabolism

Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas

Maria Chiara Zatelli et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Pharmacology & Pharmacy

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

Patrick J. Medina et al.

CLINICAL THERAPEUTICS (2008)

Review Oncology

ADAMs in cancer cell proliferation and progression

Satsuki Mochizuki et al.

CANCER SCIENCE (2007)

Review Pharmacology & Pharmacy

International Union of Pharmacology.: LXIV.: Estrogen receptors

Karin Dahlman-Wright et al.

PHARMACOLOGICAL REVIEWS (2006)

Review Genetics & Heredity

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Jeffrey A. Engelman et al.

NATURE REVIEWS GENETICS (2006)

Article Medicine, Research & Experimental

Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas

Weiping Liu et al.

JOURNAL OF MEDICAL INVESTIGATION (2005)

Article Oncology

Enhanced protein kinase B/Akt signalling in pituitary tumours

M Musat et al.

ENDOCRINE-RELATED CANCER (2005)

Review Endocrinology & Metabolism

Mechanisms of estrogen receptor signaling:: Convergence of genomic and nongenomic actions on target genes

L Björnström et al.

MOLECULAR ENDOCRINOLOGY (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Endocrinology & Metabolism

Raloxifene decreases serum IGF-I in male patients with active acromegaly

EV Dimaraki et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)

Review Endocrinology & Metabolism

Vascular endothelial growth factor: Basic science and clinical progress

N Ferrara

ENDOCRINE REVIEWS (2004)

Article Endocrinology & Metabolism

Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma

T Miyoshi et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)

Article Endocrinology & Metabolism

Dopamine receptor expression and function in corticotroph pituitary tumors

R Pivonello et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Endocrinology & Metabolism

ACTH silent adenoma shrinking under cabergoline

P Petrossians et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)

Article Medicine, General & Internal

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant

PJ Trainer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)